These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 2823278)

  • 1. Role of the endogenous leukotriene system in chronic inflammatory bowel disease.
    Dreyling KW; Kozuschek W; Schaarschmidt K; Goebell H; Peskar BM
    Prog Clin Biol Res; 1987; 242():309-15. PubMed ID: 2823278
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
    Sharon P; Stenson WF
    Gastroenterology; 1984 Mar; 86(3):453-60. PubMed ID: 6319219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
    Dreyling KW; Hoppe U; Peskar BA; Schaarschmidt K; Peskar BM
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():339-43. PubMed ID: 2889333
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
    Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
    Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
    Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
    Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is pathogenetically-founded therapy of chronic inflammatory bowel disease in sight?].
    Miller B
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():30-4. PubMed ID: 8197797
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.
    Lobos EA; Sharon P; Stenson WF
    Dig Dis Sci; 1987 Dec; 32(12):1380-8. PubMed ID: 2826090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of increased permeability of the intestinal mucosa in chronic inflammatory bowel diseases].
    Karbach U
    Z Gastroenterol Verh; 1989 Jul; 24():40-4. PubMed ID: 2474980
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of 15-keto-13,14-dihydro-prostaglandin E2 and prostaglandin D2 in human colonic tissue using a chemiluminescence enzyme immunoassay with catalase as labeling enzyme.
    Lange K; Simmet T; Peskar BM; Peskar BA
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():35-8. PubMed ID: 2936119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of prostaglandins and leukotrienes in gastroenterology].
    Peskar BM
    Internist (Berl); 1986 Oct; 27(10):637-42. PubMed ID: 3025128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis of chronic inflammatory bowel diseases].
    Ewe K
    Z Gastroenterol Verh; 1983 Apr; 18():8-20. PubMed ID: 6192613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostanoids (prostaglandins, thromboxanes, prostacyclin) and leukotrienes].
    Kecskeméti V
    Orv Hetil; 1983 Dec; 124(49):2967-74. PubMed ID: 6318174
    [No Abstract]   [Full Text] [Related]  

  • 13. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
    Schmidt C; Kosché E; Baumeister B; Vetter H
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease.
    Olbe L
    Scand J Gastroenterol; 2008; 43(2):234-41. PubMed ID: 17918000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of inflammatory bowel disease.
    Stenson WF
    Year Immunol; 1985; ():214-8. PubMed ID: 3033942
    [No Abstract]   [Full Text] [Related]  

  • 16. Cadherins: an integral role in inflammatory bowel disease and mucosal restitution.
    Zbar AP; Simopoulos C; Karayiannakis AJ
    J Gastroenterol; 2004; 39(5):413-21. PubMed ID: 15175938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis.
    Vallance BA; Gunawan MI; Hewlett B; Bercik P; Van Kampen C; Galeazzi F; Sime PJ; Gauldie J; Collins SM
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G116-28. PubMed ID: 15778431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Bidirectional sodium flux across the intestinal mucosa in Crohn's disease.
    Allan RN; Steinberg DM; Dixon K; Cooke WT
    Gut; 1974 Oct; 15(10):839-40. PubMed ID: 4434971
    [No Abstract]   [Full Text] [Related]  

  • 19. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.